CD38: A Potential Therapeutic Target in Cardiovascular Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD38: A Potential Therapeutic Target in Cardiovascular Disease

Published:2020-05-29 Issue:4 Volume:35 Page:815-828
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Zuo Wanyun,Liu Na,Zeng Yunhong,Liu Yaozhong,Li Biao,Wu Keke,Xiao Yunbin,Liu Qiming

Funder

National Natural Science Foundation of China

Hunan Provincial Natural Science Youth Foundation of China

Hunan Provincial Clinical Medical Technology Innovation Guide Project

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10557-020-07007-8.pdf

Reference148 articles.

1. Reinherz EL, Kung PC, Goldstein G, Levey RH, Schlossman SF. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci U S A. 1980;77:1588–92.

2. Howard M, Grimaldi JC, Bazan JF, Lund FE, Santos-Argumedo L, Parkhouse RM, et al. Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science. 1993;262:1056–9.

3. Aarhus R, Graeff RM, Dickey DM, Walseth TF, Lee HC. ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium-mobilizing metabolite from NADP. J Biol Chem. 1995;270:30327–33.

4. Aksoy P, White TA, Thompson M, Chini EN. Regulation of intracellular levels of NAD: a novel role for CD38. Biochem Biophys Res Commun. 2006;345:1386–92.

5. Koguma T, Takasawa S, Tohgo A, Karasawa T, Furuya Y, Yonekura H, et al. Cloning and characterization of cDNA encoding rat ADP-ribosyl cyclase / cyclic ADP-ribose hydrolase (homologue to human CD38) from islets of Langerhans. Biochimica et Biophysica Acta (BBA) - Mole Cell Res. 1994;1223:160–2.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between immune cells and epilepsy：Evidence from Mendelian randomization study and meta-analysis;2024-08-06

2. Metabolism and Receptor Mechanisms of Niacin Action;Cell and Tissue Biology;2024-04

3. Evaluation of diagnostic potential of CD38 in rickets;Molecular and Cellular Probes;2024-02

4. Targeting CD38/ ADP-ribosyl cyclase as a novel therapeutic strategy for identification of three potent agonists for leukopenia treatment;Pharmacological Research;2024-02

5. Metabolism and Receptor Mechanisms of Niacin Action;Цитология;2023-11-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3